insights_auto
Why is ARX down 4.72%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
AU$0.50
arrow_downward
-4.72%(-0.025) 1D
ኖቬም 9, 4:10:11 ከሰዓት ጂ ኤም ቲ+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
AU$0.53
High
AU$0.53
Low
AU$0.50
Mkt. cap
174.68 ሚ
Avg. vol.
298.96 ሺ
Volume
149.59 ሺ
P/E ratio
48.60
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
Open
AU$0.53
High
AU$0.53
Low
AU$0.50
Mkt. cap
174.68 ሚ
Avg. vol.
298.96 ሺ
Volume
149.59 ሺ
P/E ratio
48.60
52-wk high
AU$0.78
52-wk low
AU$0.46
EPS
AU$0.01
Shares outstanding
345.90 ሚ
No. of employees
261
News stories
From web sources and news partners
TradingView
·
ከ41 ደቂቃዎች በፊት
Avalanche: Secures clearing and settlement role for NYSE-affiliated platform - 09 Nov 2026
Dealroom
·
ከ16 ደቂቃዎች በፊት
Windward Bio targets $1B valuation in Nasdaq IPO
New York Post
·
ከ47 ደቂቃዎች በፊት
Dow surges 1,000 points after last week’s historic tech rout, while Jensen Huang’s Nvidia slumps
Yahoo Finance
·
ከ1 ሰዓት በፊት
S&P 500 Just Wiped Out $3 Trillion: Why This 0.35-Beta Stock is a Safe Haven
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd